2013 Press Releases

DATETITLE 
May 08, 2013POZEN Reports First Quarter 2013 ResultsPrinter Friendly Version
April 30, 2013POZEN Announces May 8th Webcast of First Quarter 2013 ResultsPrinter Friendly Version
April 05, 2013POZEN Announces Results from a Burden of Cardiovascular Disease Study: a Managed Care PerspectivePrinter Friendly Version
March 27, 2013POZEN Submits New Drug Application for PA32540/PA8140Printer Friendly Version
March 12, 2013POZEN Reports European Patent Office Maintains PA/VIMOVO PatentPrinter Friendly Version
March 07, 2013POZEN to Present at the 25th Annual ROTH ConferencePrinter Friendly Version
March 06, 2013POZEN Reports Fourth Quarter & Year End 2012 ResultsPrinter Friendly Version
February 27, 2013POZEN Announces March 6th Webcast of Fourth Quarter and Year End 2012 ResultsPrinter Friendly Version
February 08, 2013POZEN Presents Positive PA32540 Phase 3 Data at the 2013 International Stroke ConferencePrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

    Q1 2013 POZEN Inc. Earnings Conference Call
    05/08/13 at 11:00 a.m.ET Webcast - Replay